Detalles de la búsqueda
1.
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34493582
2.
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus.
Microb Cell Fact
; 20(1): 94, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933073
3.
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered Komagataella phaffii.
bioRxiv
; 2021 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33880471
4.
Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.
J Pharm Sci
; 110(3): 1054-1066, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33278412
5.
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens.
J Pharm Sci
; 110(3): 1042-1053, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285182
6.
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.
bioRxiv
; 2021 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33688647
Resultados
1 -
6
de 6
1
Próxima >
>>